MIR-141 AND expression of mRNAs PTEN (Phosphatase AND tensin homolog) BLOOD PLASMA IN OVARIAN TUMOR PATIENTS AND OVARIAN CANCER
ABSTRACT: Background: Epithelial Ovarian Cancer (EOC) is the most lethal gynecological malignancies among woman. The majority of this disease is diagnosed at the advanced stage due to lack of specific symptoms and effective screening methods. Therefore, an adequate biomarker for early detection is needed and may improve patient survival. microRNA is a small non-coding RNA that regulates gene expression in post-transcriptional level. Several studies have shown the ability to detect microRNA in blood circulation so microRNA may be used as a minimally invasive biomarker for EOC. microRNA - 141 (miR - 141) plays a major role in EOC by regulating expression of several tumor suppressor gene. Previous study have confirmed that miR - 141 regulated PTEN gene directly by interacting with 3 UTR sequence of PTEN mRNA. PTEN is important tumor suppressor gene that its inactivation found in various human cancer. When various studies found that PTEN mRNA and protein expression is significantly downregulated in EOC tissue, little is known about the expression of PTEN mRNA in blood circulation of EOC patient, especially in Yogyakarta population. Objective: The aims of this study is to measure and compare expression of miR - 141 and mRNA PTEN in blood plasma of ovarian tumor patient and epithelial ovarian cancer patient. Methods: This study used cross-sectional design. 25 blood plasma of ovarian tumor and 25 blood plasma of EOC were collected. Total RNA was isolated and reverse transcribed to obtain cDNA. The expression of miR - 141 and mRNA PTEN were measured by quantitative real-time polymerase chain reaction assay (qPCR). The method was used to calculate relative quantification of miR - 141 and mRNA PTEN using miR - 16 as reference gene for microRNA and beta-actin mRNA as reference genes for PTEN mRNA. Result: Expression of miR - 141 is significantly elevated in blood plasma of epithelial ovarian cancer patient compared to the ovarian tumor (p = 0,001, fold change = 7,59). Expression of PTEN mRNA significantly downregulated in blood plasma of epithelial ovarian cancer patient compared to the ovarian tumor (p = 0,001, fold change = 11,63). There was a significant negative correlation between miR - 141 expression and mRNA PTEN expression in blood plasma of epithelial ovarian cancer patient (p = 0,033; r = - 0,428). Conclusion: miR - 141 and mRNA PTEN differentially expressed in blood plasma of ovarian tumor and epithelial ovarian cancer patient. There was a negative correlation between miR - 141 and mRNA PTEN expression in blood plasma of epithelial ovarian cancer patient.
ABSTRACT: Background: Epithelial Ovarian Cancer (EOC) is the most lethal gynecological malignancies among woman. The majority of this disease is diagnosed at the advanced stage due to lack of specific symptoms and effective screening methods. Therefore, an adequate biomarker for early detection is needed and may improve patient survival. microRNA is a small non-coding RNA that regulates gene expression in post-transcriptional level. Several studies have shown the ability to detect microRNA in blood circulation so microRNA may be used as a minimally invasive biomarker for EOC. microRNA - 141 (miR - 141) plays a major role in EOC by regulating expression of several tumor suppressor gene. Previous study have confirmed that miR - 141 regulated PTEN gene directly by interacting with 3 UTR sequence of PTEN mRNA. PTEN is important tumor suppressor gene that its inactivation found in various human cancer. When various studies found that PTEN mRNA and protein expression is significantly downregulated in EOC tissue, little is known about the expression of PTEN mRNA in blood circulation of EOC patient, especially in Yogyakarta population. Objective: The aims of this study is to measure and compare expression of miR - 141 and mRNA PTEN in blood plasma of ovarian tumor patient and epithelial ovarian cancer patient. Methods: This study used cross-sectional design. 25 blood plasma of ovarian tumor and 25 blood plasma of EOC were collected. Total RNA was isolated and reverse transcribed to obtain cDNA. The expression of miR - 141 and mRNA PTEN were measured by quantitative real-time polymerase chain reaction assay (qPCR). The method was used to calculate relative quantification of miR - 141 and mRNA PTEN using miR - 16 as reference gene for microRNA and beta-actin mRNA as reference genes for PTEN mRNA. Result: Expression of miR - 141 is significantly elevated in blood plasma of epithelial ovarian cancer patient compared to the ovarian tumor (p = 0,001, fold change = 7,59). Expression of PTEN mRNA significantly downregulated in blood plasma of epithelial ovarian cancer patient compared to the ovarian tumor (p = 0,001, fold change = 11,63). There was a significant negative correlation between miR - 141 expression and mRNA PTEN expression in blood plasma of epithelial ovarian cancer patient (p = 0,033; r = - 0,428). Conclusion: miR - 141 and mRNA PTEN differentially expressed in blood plasma of ovarian tumor and epithelial ovarian cancer patient. There was a negative correlation between miR - 141 and mRNA PTEN expression in blood plasma of epithelial ovarian cancer patient.
